{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:30:39Z","timestamp":1762101039140},"reference-count":33,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.ejphar.2010.04.012","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T08:48:58Z","timestamp":1271666938000},"page":"13-20","source":"Crossref","is-referenced-by-count":4,"title":["Sodium salicylate acts through direct inhibition of phosphoinositide 3-kinase-like kinases to modulate topoisomerase-mediated DNA damage responses"],"prefix":"10.1016","volume":"638","author":[{"given":"Jia-Rong","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Yu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang-Long","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai-Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.04.012_bib1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1517\/13543784.13.10.1327","article-title":"From chemoprevention to chemotherapy: common targets and common goals","volume":"13","author":"Aggarwal","year":"2004","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2010.04.012_bib2","doi-asserted-by":"crossref","first-page":"11014","DOI":"10.1073\/pnas.0704002104","article-title":"From the cover: roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies","volume":"104","author":"Azarova","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2010.04.012_bib3","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V92.4.1406","article-title":"Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells","volume":"92","author":"Bellosillo","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2010.04.012_bib4","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1128\/MCB.15.10.5700","article-title":"scid cells are deficient in Ku and replication protein A phosphorylation by the DNA-dependent protein kinase","volume":"15","author":"Boubnov","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2010.04.012_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1097-2765(04)00056-5","article-title":"Repair of DNA covalently linked to protein","volume":"13","author":"Connelly","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2010.04.012_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nature03442","article-title":"Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage","volume":"434","author":"Falck","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2010.04.012_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.dnarep.2007.12.002","article-title":"Cellular processing pathways contribute to the activation of etoposide-induced DNA damage responses","volume":"7","author":"Fan","year":"2008","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.ejphar.2010.04.012_bib8","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1089\/ars.2005.7.1630","article-title":"Chemosensitization and radiosensitization of tumors by plant polyphenols","volume":"7","author":"Garg","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejphar.2010.04.012_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","article-title":"Curcumin as \u201cCurecumin\u201d: from kitchen to clinic","volume":"75","author":"Goel","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.04.012_bib10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1200\/JCO.2005.08.097","article-title":"Colorectal cancer prevention","volume":"23","author":"Hawk","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2010.04.012_bib11","doi-asserted-by":"crossref","first-page":"26325","DOI":"10.1074\/jbc.272.42.26325","article-title":"Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice","volume":"272","author":"Huang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.04.012_bib12","doi-asserted-by":"crossref","first-page":"9501","DOI":"10.1074\/jbc.275.13.9501","article-title":"NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events","volume":"275","author":"Huang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.04.012_bib13","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1124\/mol.107.043554","article-title":"The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway","volume":"73","author":"Javvadi","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.04.012_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrd1609","article-title":"Multicomponent therapeutics for networked systems","volume":"4","author":"Keith","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2010.04.012_bib15","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood.V93.7.2386","article-title":"Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines","volume":"93","author":"Klampfer","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2010.04.012_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.pharmtox.41.1.53","article-title":"Tumor cell death induced by topoisomerase-targeting drugs","volume":"41","author":"Li","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2010.04.012_bib17","first-page":"8400","article-title":"Characterization of ARC-111 as a novel topoisomerase I-targeting anticancer drug","volume":"63","author":"Li","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2010.04.012_bib18","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1158\/0008-5472.CAN-06-3431","article-title":"Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon","volume":"67","author":"Liou","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2010.04.012_bib19","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1124\/mol.108.049569","article-title":"Nonsteroidal anti-inflammatory drugs induced endothelial apoptosis by perturbing peroxisome proliferator-activated receptor-delta transcriptional pathway","volume":"74","author":"Liou","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.04.012_bib20","doi-asserted-by":"crossref","first-page":"14540","DOI":"10.1073\/pnas.95.24.14540","article-title":"Modes of action of aspirin-like drugs: salicylates inhibit erk activation and integrin-dependent neutrophil adhesion","volume":"95","author":"Pillinger","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2010.04.012_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mnfr.200700326","article-title":"Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways","volume":"52","author":"Ramos","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejphar.2010.04.012_bib22","first-page":"1464","article-title":"Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent","volume":"55","author":"Rao","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2010.04.012_bib23","doi-asserted-by":"crossref","first-page":"8925","DOI":"10.1128\/MCB.25.20.8925-8937.2005","article-title":"Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage","volume":"25","author":"Rao","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2010.04.012_bib24","doi-asserted-by":"crossref","first-page":"8089","DOI":"10.1074\/jbc.271.14.8089","article-title":"Inhibition of tumor necrosis factor-induced p42\/p44 mitogen-activated protein kinase activation by sodium salicylate","volume":"271","author":"Schwenger","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2010.04.012_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/MCB.18.1.78","article-title":"Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation","volume":"18","author":"Schwenger","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejphar.2010.04.012_bib26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1568011033482378","article-title":"Apoptosis induced by topoisomerase inhibitors","volume":"3","author":"Sordet","year":"2003","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"key":"10.1016\/j.ejphar.2010.04.012_bib27","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1096\/fj.01-0390rev","article-title":"Cyclooxygenase-independent actions of cyclooxygenase inhibitors","volume":"15","author":"Tegeder","year":"2001","journal-title":"Faseb J."},{"key":"10.1016\/j.ejphar.2010.04.012_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues","volume":"94","author":"Thun","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejphar.2010.04.012_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc1801","article-title":"Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics","volume":"6","author":"Ulrich","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2010.04.012_bib30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/10577","article-title":"Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB","volume":"5","author":"Wang","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2010.04.012_bib31","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1073\/pnas.97.4.1584","article-title":"The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest","volume":"97","author":"Wang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2010.04.012_bib32","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1093\/emboj\/cdf307","article-title":"DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53","volume":"21","author":"Woo","year":"2002","journal-title":"Embo J."},{"key":"10.1016\/j.ejphar.2010.04.012_bib33","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/carcin\/bgg137","article-title":"ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses","volume":"24","author":"Yang","year":"2003","journal-title":"Carcinogenesis"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910003183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910003183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T21:10:33Z","timestamp":1591218633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910003183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":33,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0014299910003183"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.04.012","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}